1. Home
  2. INTT vs FATE Comparison

INTT vs FATE Comparison

Compare INTT & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTT
  • FATE
  • Stock Information
  • Founded
  • INTT 1981
  • FATE 2007
  • Country
  • INTT United States
  • FATE United States
  • Employees
  • INTT N/A
  • FATE N/A
  • Industry
  • INTT Semiconductors
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INTT Technology
  • FATE Health Care
  • Exchange
  • INTT Nasdaq
  • FATE Nasdaq
  • Market Cap
  • INTT 105.8M
  • FATE 116.5M
  • IPO Year
  • INTT 1997
  • FATE 2013
  • Fundamental
  • Price
  • INTT $8.35
  • FATE $1.09
  • Analyst Decision
  • INTT Strong Buy
  • FATE Buy
  • Analyst Count
  • INTT 2
  • FATE 7
  • Target Price
  • INTT $12.00
  • FATE $3.92
  • AVG Volume (30 Days)
  • INTT 49.4K
  • FATE 2.5M
  • Earning Date
  • INTT 11-05-2025
  • FATE 11-12-2025
  • Dividend Yield
  • INTT N/A
  • FATE N/A
  • EPS Growth
  • INTT N/A
  • FATE N/A
  • EPS
  • INTT N/A
  • FATE N/A
  • Revenue
  • INTT $117,606,000.00
  • FATE $8,470,000.00
  • Revenue This Year
  • INTT N/A
  • FATE N/A
  • Revenue Next Year
  • INTT $10.38
  • FATE N/A
  • P/E Ratio
  • INTT N/A
  • FATE N/A
  • Revenue Growth
  • INTT N/A
  • FATE N/A
  • 52 Week Low
  • INTT $5.24
  • FATE $0.66
  • 52 Week High
  • INTT $9.77
  • FATE $3.50
  • Technical
  • Relative Strength Index (RSI)
  • INTT 49.94
  • FATE 36.73
  • Support Level
  • INTT $8.33
  • FATE $1.28
  • Resistance Level
  • INTT $8.99
  • FATE $1.51
  • Average True Range (ATR)
  • INTT 0.50
  • FATE 0.16
  • MACD
  • INTT -0.04
  • FATE -0.06
  • Stochastic Oscillator
  • INTT 47.15
  • FATE 1.16

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: